Position in ASND
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$22,873
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Innovative Asset Advisors Group, LLC holds $368,239 across 22 Biotechnology names. ASND ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
|
21,100 | $64,777 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
1,727 | $56,196 | |
| 3 | TECH |
BIO-TECHNE Corp
|
882 | $46,093 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
96 | $42,867 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
46 | $35,541 | |
| 6 | EXEL |
Exelixis, Inc.
|
656 | $28,135 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
100 | $22,873 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
772 | $16,798 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,873 | 100 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||